Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
CellSource, Ordinary Profit Unexpectedly Turn to Loss for Last Fiscal Year, The Current Fiscal Year's Ordinary Profit Turns to Loss, Falling into no Dividends
[Summary]Consolidated Financial Results for the Fiscal Year Ended October 31, 2025(Under Japanese GAAP)
Notice Concerning the Write-Down of Deferred Tax Assets and Difference between Consolidated Financial Forecasts and Actual Results
Notice Regarding Policy for Transition to the TSE Standard Market
October 2025 Monthly KPI Fiscal Year Ending October 2025
CellSource’s Blood-derived Processing Service Introduced at Hyogo Medical University Hospital, Department of Orthopedic Surgery
Notice Concerning Selection as Loan Margin Trading Issue
September 2025 Monthly KPI Fiscal Year Ending October 2025
Earnings Presentation Q3 FY10 2025
CellSource and Juntendo University Announce Research Findings on New Therapeutic Possibilities for Chronic Cerebral Infarction
Notice Concerning Revisions to Full-Year Financial Results Forecasts
CellSource and KAKEN PHARMACEUTICAL Initiate Discussions Toward a New Collaboration Framework
CellSource, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 45%
[Summary]Consolidated Financial Results for the Nine Months Ended July 31, 2025 (Under Japanese GAAP)
CellSource and Solallis Bio Enter into Comprehensive Business Alliance Agreement in the Regenerative Medicine Field
July 2025 Monthly KPI Fiscal Year Ending October 2025
Notice Regarding Change in Representative and Representative Director
June 2025 Monthly KPI Fiscal Year Ending October 2025
Notice Regarding Determination of Terms for Stock Options (Stock Acquisition Rights)
Earnings Presentation Q2 FY10/2025